[2] Ruthy Glass, New Demand in an Old Market , IQVIA (September 5, 2023)
Dziaanie [edytuj | edytuj kod] Tirzepatyd jest lekiem podwjnie celowanym: aktywuje zarwno receptory GLP-1, jak i GIP, bdce hormonami regulujcymi poziom cukru we krwi [1]
-
[DOI] [PMC free article] [PubMed] [Google Scholar] 73.Yamada K., Inoue H., Kida S., Masushige S., Nishiyama T., Mishima K., Saito I
For patients who prefer avoiding injections, this program removes a common barrier to starting medical weight loss
GLP-1R is widely expressed in the whole body, mainly in the lungs, kidneys, heart, adipose tissue, and the central and peripheral nervous systems [3]